Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Collins

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Current Protocols|July 18, 2024
Expanded Antigen-Specific Elimination Assay to Measure Human CD8<sup>+</sup> T Cell Cytolytic PotentialDavid R Collins, Mpho J Olatotse, Zachary J Racenet, et al.
Science Immunology|May 19, 2023
Cytolytic CD8<sup>+</sup> T cells infiltrate germinal centers to limit ongoing HIV replication in spontaneous controller lymph nodesDavid R Collins, Julia Hitschfel, Jonathan M Urbach, et al.
Elife|March 3, 2020
Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophagesJay Lubow, Maria C Virgilio, Madeline Merlino, et al.
Science (New York, N.Y.)|January 18, 2024
Impact of HLA class I functional divergence on HIV controlMathias Viard, Colm O'hUigin, Yuko Yuki, et al.
Nature|December 1, 2025
CD8<sup>+</sup> T cell stemness precedes post-intervention control of HIV viremiaZahra Kiani, Jonathan M Urbach, Hannah Wisner, et al.
Science (New York, N.Y.)|May 4, 2019
Structural topology defines protective CD8<sup>+</sup> T cell epitopes in the HIV proteomeGaurav D Gaiha, Elizabeth J Rossin, Jonathan Urbach, et al.
Immunity|September 8, 2021
Functional impairment of HIV-specific CD8<sup>+</sup> T cells precedes aborted spontaneous control of viremiaDavid R Collins, Jonathan M Urbach, Zachary J Racenet, et al.
Nature Communications|May 22, 2023
Molecular basis of differential HLA class I-restricted T cell recognition of a highly networked HIV peptideXiaolong Li, Nishant Kumar Singh, David R Collins, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2020
Concanamycin A counteracts HIV-1 Nef to enhance immune clearance of infected primary cells by cytotoxic T lymphocytesMark M Painter, Gretchen E Zimmerman, Madeline S Merlino, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Duration of Initial Viremia Modulates Functional Properties of HIV-specific T Cell ReceptorsFunsho J Ogunshola, Nishant K Singh, Vincent Butty, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Current Protocols|July 18, 2024
Expanded Antigen-Specific Elimination Assay to Measure Human CD8<sup>+</sup> T Cell Cytolytic PotentialDavid R Collins, Mpho J Olatotse, Zachary J Racenet, et al.
Science Immunology|May 19, 2023
Cytolytic CD8<sup>+</sup> T cells infiltrate germinal centers to limit ongoing HIV replication in spontaneous controller lymph nodesDavid R Collins, Julia Hitschfel, Jonathan M Urbach, et al.
Elife|March 3, 2020
Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophagesJay Lubow, Maria C Virgilio, Madeline Merlino, et al.
Science (New York, N.Y.)|January 18, 2024
Impact of HLA class I functional divergence on HIV controlMathias Viard, Colm O'hUigin, Yuko Yuki, et al.
Nature|December 1, 2025
CD8<sup>+</sup> T cell stemness precedes post-intervention control of HIV viremiaZahra Kiani, Jonathan M Urbach, Hannah Wisner, et al.
Science (New York, N.Y.)|May 4, 2019
Structural topology defines protective CD8<sup>+</sup> T cell epitopes in the HIV proteomeGaurav D Gaiha, Elizabeth J Rossin, Jonathan Urbach, et al.
Immunity|September 8, 2021
Functional impairment of HIV-specific CD8<sup>+</sup> T cells precedes aborted spontaneous control of viremiaDavid R Collins, Jonathan M Urbach, Zachary J Racenet, et al.
Nature Communications|May 22, 2023
Molecular basis of differential HLA class I-restricted T cell recognition of a highly networked HIV peptideXiaolong Li, Nishant Kumar Singh, David R Collins, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2020
Concanamycin A counteracts HIV-1 Nef to enhance immune clearance of infected primary cells by cytotoxic T lymphocytesMark M Painter, Gretchen E Zimmerman, Madeline S Merlino, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Duration of Initial Viremia Modulates Functional Properties of HIV-specific T Cell ReceptorsFunsho J Ogunshola, Nishant K Singh, Vincent Butty, et al.
Pageof 4